The $.245 is conjecture on my part only, not a legal tender offer. I provided the math I used to arrive at the value, but I have nothing more to substantiate the validity of my claim.
I am not aware of a pending Form 15, Form S-1, going private, or reverse merger.
I am aware, because it is publicly stated, the company intends to use the proceeds from the RS to finance the trials in the US and to finance commercialization of the product/process in Europe. Also, the company is seeking additional long term financing.
There are many opportunities and possibilities. I have not seen anything written in a SEC filing or press release from Delcath to make them believable.
If anyone has pertinent information to any of these scenarios, I would be most grateful if they would share.
All the best.
MM
News 
Market Data 
Discover 
